Stay updated on Surufatinib Plus Sintilimab in Advanced Solid Tumor Clinical Trial
Sign up to get notified when there's something new on the Surufatinib Plus Sintilimab in Advanced Solid Tumor Clinical Trial page.

Latest updates to the Surufatinib Plus Sintilimab in Advanced Solid Tumor Clinical Trial page
- Check2 days agoNo Change Detected
- Check10 days agoChange DetectedRevision label updated from v3.6.3 to v3.6.4, signaling a minor platform update. No study content or results appear to be affected.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedRevision updated from v3.6.2 to v3.6.3, indicating a small page version update and no change to the study information or criteria.SummaryDifference0.1%

- Check38 days agoChange DetectedThe page revision tag was updated from v3.6.0 to v3.6.2, indicating a small maintenance update to the page rendering and metadata. No study data or content changes are indicated by this update.SummaryDifference0.1%

- Check53 days agoChange DetectedThe study page now indicates recruitment is closed to participants, and new help sections have been added (How to Read a Study Record, Common Questions, How to Join a Study) along with a formatting update to the Intervention/Treatment header and a revision/version change from v3.5.5 to v3.6.0.SummaryDifference0.7%

- Check60 days agoChange DetectedRevision label updated from v3.5.4 to v3.5.5, indicating a new page version. The update appears to be a minor version bump rather than a substantive change to the study details or associated content.SummaryDifference0.1%

- Check81 days agoChange DetectedThe page now shows Revision: v3.5.4, replacing the previous Revision: v3.5.3. This indicates an update to the site's template or rendering rather than any study-specific content.SummaryDifference0.1%

Stay in the know with updates to Surufatinib Plus Sintilimab in Advanced Solid Tumor Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Surufatinib Plus Sintilimab in Advanced Solid Tumor Clinical Trial page.